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The DNA synthesis of lymph~yt~s triggered by phytohema~lutinin or phorboi-myristate-acetate is strong- 
ly reduced by the externally applied etectromagnetic field (ELF). Ca2+ uptake by stimulated lymphocytes 
is also reduced by ELF. The effect appears to be synergistic with that of the well-known calcium blocker 
agent, verapamil. 
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1. INTRODUCTION 
The interaction of ELF on several biological 
systems has been extensively studied [I]. In par- 
ticular, ELF has recentiy been proven to increase 
the rate of healing of bone fracture in man [2,3]. 
Furthermore, ELF has been reported to affect the 
immune system [4], the cell differentiation [5] and 
the arachidonic acid cascade [6]. 
Though the mechanism of ELF action has not 
yet been established it seems that a role for Ca2’ 
can be envisaged. In fact, each of the biological 
phenomena ffected by ELF requires Ca2+ in some 
step. 
In [4] we showed that ELF reduces the extent of 
lymphocyte blastization induced by Iectins and we 
proposed that the eIectromagnetic field co&d af- 
fect the movement of Ca2+ across the plasma 
membrane. 
Abbreviations: ELF, very low frequency elec- 
tromagnetic field; PHA, phytohemagglutinin; PMA, 
phorbol-myristate-acetate; CRPMI, complete medium 
RPM1 1640 
Here we tried to confirm this hypothesis by stu- 
dying the effect of ELF on PHA and PMA 
stimulated lymphocytes. A role for Ca2* was sup- 
ported by the effect of Ca’+ inhibitor verapamil 
and by the direct measurements of Ca2+ fluxes 
studied by 45Ca. 
2. MATERIALS AND METHODS 
2.1. Isolation of human mononuclear cells 
Heparinized blood samples were obtained from 
adult normal volunteers and PBMC were collected 
on Ficoll-Hypaque as in [7], washed twice with 
Hepes-buffered (10 mM) Hanks balanced salt 
solution and resuspended in RPM1 1640 medium 
supplemented with 10% heat-inactivated Fetal 
Calf serum, penicillin 6 (200 U/ml), gentamicin 
(lO~g/ml), L-glutamine (0.3 mg/ml) and 10 mM 
Hepes, henceforth referred to as compIete medium 
(CRPMI). 
These cells were cultured for 72 h at 37”C,in a 
5% COz-humidified atmosphere, in 200,,~1 of 
CRPMI at a concentration of 1 x IO6 cells/ml in 
multiwell plates in the presence and absence of 
phorbol ester (final concentration, 8sglml) or 
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PHA-p Difco (final concentration, 20,0g/ml). In 
some wells, verapamil at final concentrations of 
5 pg and 25 pg/ml was also added. 
2.2. Exposure to ELF 
The ELF was generated by passing a current 
through a pair of concentric 966-turn coils, 10 cm 
radius, separated by 2 cm. The device in question 
was wired in parallel to a pulse generator which 
gave a train of pulses of variable form and intensi- 
ty. Square pulses with a frequency of 3 Hz were 
used. The generated field had an intensity of 
-60 G. The waveform of current passing in the 
coils was only weakly smoothed due to the in- 
ductance of the two coil system (249 mH). The 
magnitude and waveform of the field was checked 
by using a Hall-effect probe. The temperature be- 
tween the coils was measured with a digital ther- 
mometer. The coils were placed in a tissue culture 
incubator held at 37°C while the pulse generator 
unit was outside. 
The cells were exposed to ELF in the wells of a 
microtiter plate. Only those wells which showed an 
ELF homogeneity better than 1% when placed in 
the central space between the coils were used. 
2.3. Assay for Cd’ inj7ux 
A standard radiolabeling technique was used to 
measure cell associated 45Ca2+ in the cell samples 
[S]. A lymphocyte suspension (0.1 ml, 2 x lo7 
cells/ml) in Ca2+ free MEM was incubated with 
10 pl lectin or buffer (1 &i, specific activity 
30 Ci/g, NEN-USA) at 37°C. After 1 h 0.4 ml of 
ice-cold 10 mM CaCl2 in saline was added. The 
tubes were immediately centrifuged for 3O.s, then 
washed twice with fresh ice-cold CaClz-saline. The 
radioactivity of 45Ca2+ incorporated into the cells 
was measured by scintillation spectrometry. 
2.4. Experimental procedures 
The first series of experiments were conducted 
by exposing the PHA and PMA stimulated lym- 
phocyte cultures (quintuplicate) to ELF and 
verapamil alone and in combination. The cultures 
were exposed during the whole incubation time 
(72 h). The t3H]thymidine (25 mCi/mM) was add- 
ed to a final concentration of 2 ,&i/ml, 6 h before 
the end of the incubation. At the end of the culture 
the cell viability was evaluated by trypan blue ex- 
clusion, it was always over 90% both when ex- 
posed and when not exposed. No appreciable dif- 
Table 1 
Incorporation of [3H]thymidine by lymphocytes in the presence and absence of ELF 
Row no. No field Field= No field Field= 
1 Control 
2 PHA 
3 PMA 
4 PHA + VRP.1 
5 PHA + VRP.2 
6 PMA + VRP.l 
7 PMA + VRP.2 
1 Control 
2 PHA 
3 PMA 
4 PHA + VRPl 
5 PHA + VRP2 
6 PMA + VRPI 
7 PMA + VRP2 
1st Experiment 
2818 f 832 3221 f 965 
241045 k 10023 159020 + 12404 
39880 f 6933 14293 f 5735 
43216 k 8951 27586 f 6663 
179 178 f 21616 145778 * 7737 
1680 + 705 7073 f 1291 
9878 f 2017 22508 f 16621 
3rd Experiment 
6767 + 1661 3872 f 1292 
264065 f 65 159 68892 f 21571 
30687 f 14351 7330 f 4116 
21265 + 4574 4277 f 1167 
88905 + 21368 31770 f 7485 
2950 + 684 386 + 73 
8452 + 2395 3535 f 1669 
2nd Experiment 
5928 + 784 6200 f 639 
101576 + 9907 65343 k 5148 
30225 f 11047 5791 + 2363 
7236 + 1550 10743 + 850 
35451 + 3327 26226 + 4584 
6786 + 2693 2413 + 583 
18017 f 4521 15531 f 4232 
4th Experiment 
5101 k 2486 4507 + 2210 
213905 +z 59276 67976 f 14887 
83025 + 39629 16570 k 6590 
55970 z!z 15514 17932 + 9421 
111298 + 13892 47830 + 13734 
3286 f 1548 1806 -+ 714 
10407 * 1816 5406 + 2368 
a A 3 Hz and -60 G square waveform field 
PHA, phytohemagglutinin; PMA, phorbolmyristateacetate; VRP, verapamil; 1 = 25 pM, 2 = 5 ,uM 
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ference in pH between the cultures incubated with 
and without field was observed, as measured with 
a digital pH-meter. At the end of the incubation, 
the cells were harvested with glass fiber filters us- 
ing a semiautomatic multiple sample precipitator, 
air-dried and the radioactivity was determined with 
a counter. Significance of the difference between 
the measured radioactivity mean values in dif- 
ferent culture conditions was tested by Student’s t- 
test. 
In another set of experiments we measured the 
Ca*+ influx in PHA- and PMA-stimulated lym- 
phocytes after exposure to ELF and treatment with 
verapamil. 
3. RESULTS 
Table 1 shows the effect of ELF on the incor- 
poration of thymidine into normal human lym- 
phocytes stimulated by PHA (rows 2,4 and 5) or by 
PMA (rows 3,6 and 7) as such (row l-3) or in the 
presence of verapamil (rows 4-7). 
The mitogenic effect of PHA or PMA appears 
to be markedly reduced by the exposure to ELF 
and by treatment with verapamil. In fact, the dif- 
ferences between the incorporation of thymidine in 
the presence or absence of field and in the presence 
and absence of verapamil are always highly signifi- 
cant @ c 0.01). The two inhibitory effects seem to 
be additive. 
Fig. 1. Dependence of percent inhibition of 
[3H]thymidine incorporation by verapamil concentra- 
tions: (a) no field present; (b) 3 Hz and -60 G square 
waveform field applied. For experimental details see 
Fig.la shows that the percentage reduction of 
thymidine incorporation is linearly related, in a 
log-log representation, to the verapamil concentra- 
tion added to the cell cultures. A similar behaviour 
was obtained when the ELF was applied to the cell 
culture. This experimental evidence may indicate 
February 1985 
verapamil 
verapamil 
section 2. 
Table 2 
Calcium uptake by lymphocytes in the presence and absence of ELF 
Control 
PHA 
PHA + VRP 
(25 PM) 
Control 
PMA 
PMA + VRP 
(25 PM) 
No field Fielda 
1st Experiment 
1062 + 59 968 + 35 
1407 f 94 838 + 26 
1020 f 48 520 2 40 
1212 f 229 985 rt_ 20 
3900 -t 700 896 f 400 
1800 f 145 800 f 112 
No field Fielda 
2nd Experiment 
2797 & 120 3010 + 62 
3298 + 214 2586 + 50 
2362 + 108 2598 + 51 
3008 + 245 3300 + 275 
4200 f 207 3275 z!z 301 
3200 * 275 3450 + 190 
No field Fielda 
3rd Experiment 
4328 +I 302 4378 + 62 
5076 + 407 5076 f 32 
3514 + 201 3470 + 45 
2049 + 49 2290 + 137 
2774 + 189 1761’5 53 
1172 + 113 2170 + 207 
a A 3 Hz and -60 G square waveform field 
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that ELF does not interfere with the verapamil ef- 
fect on calcium. 
Table 2 shows that more 45Ca2+ is incorporated 
by cells after stimulation with PHA and PMA. 
However, both ELF and verapamil reduce the up- 
take of 45Ca2+ to the value of controls. In this case 
a synergic effect of ELF and verapamil was not 
apparent. 
4. DISCUSSION 
In a previous paper we hypothesised that the ex- 
posure to ELF reduced the extent of lymphocyte 
blastogenesis due to a reduction of Ca2+ flux 
across the plasma-membrane, occurring within the 
first minutes after the addition of the lectins [5]. 
To support this idea in these experiments we have 
studied the combined effect of ELF and verapamil 
on lymphocytes after stimulation with PHA and 
PMA. Verapamil is a drug that blocks Ca2+ chan- 
nels or pores then modifying the Ca2+ permeability 
of cell membranes [9,10]. 
Calcium may be a second intracellular 
messenger and indeed it has been considered a 
mediator of phorbol ester effects. Mobilization of 
Ca*+ from an intracellular pool is thought to trig- 
ger or regulate many PMA-induced biological 
responses. In addition, PMA was reported to in- 
duce changes in membrane potential and calcium 
influx and PMA stimulation of DNA synthesis was 
reported to be dependent on extracellular calcium 
[l 11. Exogenous Ca2+ has been reported to play a 
role in the initiation of T cell activation [12,13] 
that eventually gives rise to DNA synthesis [14,15]. 
Here we have shown that the stimulation of 
DNA synthesis with PHA and PMA is accom- 
panied by an increased 45Ca2+ uptake by lym- 
phocytes (table 2). Similar reports have already 
been published [ 161. 
We have also shown that ELF and verapamil are 
strong inhibitors of PHA- and PMA-induced 
stimulation of human lymphocytes. The inhibition 
seems always to imply a reduced flux of Ca*+ into 
the cell as shown by the 45Ca experiments (table 2). 
The combined action of ELF and verapamil 
gives an inhibition greater than that produced by 
each factor. This additivity might be related either 
to the non-saturation condition used for each in- 
hibitor or to different targets for the two agents. 
The second hypothesis might imply that ELF is ac- 
ting only on the flux of extracellular Ca”, like 
verapamil that is also able to interfere with the 
mobilization of extracellular Ca2+, but maybe with 
a different mechanism. 
The results reported above appear to confirm 
the effect of ELF on plasma membranes already 
proposed [ 171. Additional evidence is needed to 
determine whether the reduced flux of Ca2+ is the 
only (or the most important) effect underlying the 
action of ELF. 
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